The Lagos Marriott Hotel in Ikeja became the epicenter for oncology innovation as we hosted the 3rd edition of the Brachytherapy Summit. The event was a resounding success, bringing together a full house of Nigeria’s leading healthcare professionals, international experts, and key policymakers, all united by a common goal: to revolutionize cancer treatment in our nation.
We were deeply honoured by the presence of our distinguished guests, particularly the esteemed Chairman of the Summit, Professor Francis Durosinmi-Etti, a foundational figure in Nigerian radiotherapy. His leadership, alongside the vision of Medserve’s CEO, Dr. Tolulope Adewole, set the tone for a day of powerful collaboration and forward-thinking discussion.
The energy in the room was a testament to the collective commitment to progress. The sessions delivered insightful and impactful presentations from a truly diverse and powerful coalition of organizations. We witnessed a seamless exchange of knowledge between local pioneers from Medserve, Medserve LUTH Cancer Centre (MLCC), LUTH, the Nigerian Nuclear Regulatory Authority (NNRA), the National Institute for Cancer Research and Treatment (NICRAT), and UCH Ibadan.
This local expertise was enriched by a global perspective, with invaluable contributions from international powerhouses like India’s Tata Memorial Centre, the USA’s Memorial Sloan Kettering Cancer Center (MSKCC) and Weill Cornell Medicine, and the globally recognized HCG.
This landmark event would not have been possible without the generous support of our sponsors: Medserve, TANIT Medical, HCG, and LUTH. Your commitment is a direct investment in a healthier future for Nigeria.
The Brachytherapy Summit was more than just a conference; it was a declaration of intent. It showcased the immense power of collaboration and set a new standard for advancing specialized cancer care, like brachytherapy, not just in Nigeria but across the globe. The future of cancer care is bright, and together, we are leading the charge.
